Potential Therapeutic Targets for Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma

被引：0
|
作者：
Weiss, Vivian L.
Gonzalez, Raul S.
Shi, Chanjuan
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
818
引用
收藏
页码：206A / 207A
页数：2
相关论文
共 50 条
  • [41] Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient
    Bhatla, Teena
    Dandekar, Smita
    Lu, Benjamin Y.
    Wang, Jinhua
    Han, Eugenia
    Bitterman, Danielle
    Jones, Courtney L.
    Evensen, Nikki A.
    Magid, Margret
    Meyer, Julia A.
    Carroll, William L.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (01) : E21 - E25
  • [42] HSP90 Expression and Early Recurrence in Gastroenteropancreatic Neuroendocrine Tumors: Potential for Novel Therapeutic Targets
    Ethun, C. G.
    Postlewait, L. M.
    Lopez-Aguiar, A. G.
    Zhelnin, K.
    Krasinskas, A.
    El-Rayes, B.
    Russell, M.
    Kooby, D.
    Staley, C. A.
    Cardona, K.
    Maithel, S. K.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S97 - S97
  • [43] Editorial Comment to Poorly differentiated neuroendocrine carcinoma of the seminal vesicle
    Nakamura, Masafumi
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (04) : 372 - 373
  • [44] Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma
    Daniel P. Lindholm
    Barbro Eriksson
    Dan Granberg
    Medical Oncology, 2012, 29 : 301 - 303
  • [45] Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system
    Pellat, Anna
    Wislez, Marie
    Svrcek, Magali
    Hammel, Pascal
    Afchain, Pauline
    Andre, Thierry
    BULLETIN DU CANCER, 2016, 103 (10) : 880 - 895
  • [46] Poorly Differentiated Neuroendocrine Tumors
    Eads, Jennifer R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 151 - +
  • [47] Neuroendocrine factors as potential therapeutic targets
    Jezova, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 51 - 51
  • [48] Genomic Profiling Distinguishes Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (GEP-NEC) from Small Cell Lung Carcinoma (SCLC)
    Bergsland, Emily
    Roy, Ritu
    Elvin, Julia
    Graeme-Cook, Fiona
    Bailey, Mark
    Stephens, Phil
    Ross, Jeffrey
    Olshen, Adam
    PANCREAS, 2017, 46 (03) : 427 - 427
  • [49] Clinicopathologic analysis of primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center
    Bukhari, Mulazim Hussain
    Coppola, Domenico
    Nasir, Aejaz
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2020, 36 (02) : 265 - 270
  • [50] High-Grade Poorly Differentiated Neuroendocrine Carcinomas of the Gastroenteropancreatic System: from Morphology to Proliferation and back
    La Rosa, Stefano
    Sessa, Fausto
    ENDOCRINE PATHOLOGY, 2014, 25 (02) : 193 - 198
12345